Research Article
Health Status and Patient Satisfaction after Corneal Graft: Results from the Corneal Transplant Epidemiological Study
Table 4
PCS-12 and MCS-12 (mean and 95% CI) and effect size (ES) by subgroups.
| ββ | | PCS-12 | MCS-12 | | | | | | | ES* |
| Total | 1,223 | 50.8 (50.4β51.2) | 50.2 (49.8β50.6) | 0.09 | 48.4 (47.8β49.0) | 50.4 (49.8β51.0) | 0.19 |
| Gender | | | | | | | | βMale | 719 | 51.5 (51.0β51.9) | 51.4 (50.9β51.9) | β0.01 | 50.8 (50.1β51.4) | 52.4 (51.7β53.1) | 0.18 | βFemale | 504 | 49.9 (49.3β50.6) | 48.5 (47.8β49.2) | β0.18 | 45.0 (44.0β46.0) | 47.6 (46.6β48.6) | 0.23 | Male, age groups (y) | | | | | | | | β18β24 | 88 | 52.8 (51.5β54.2) | 52.5 (51.3β53.7) | β0.06 | 49.8 (47.8β51.9) | 51.0 (48.9β53.0) | 0.12 | β25β34 | 178 | 51.9 (51.0β52.8) | 52.7 (51.9β53.5) | 0.13 | 50.5 (49.3β51.7) | 53.1 (52.0β54.2) | 0.33 | β35β44 | 155 | 51.5 (50.6β52.5) | 51.5 (50.5β52.6) | β | 49.8 (48.2β51.3) | 51.2 (49.7β52.6) | 0.15 | β45β54 | 111 | 52.1 (50.8β53.3) | 51.3 (50.0β52.6) | β0.11 | 49.3 (47.3β51.2) | 51.3 (49.4β53.1) | 0.19 | β55β64 | 85 | 50.3 (49.1β51.6) | 51.0 (49.7β52.1) | 0.10 | 52.2 (50.1β54.2) | 54.9 (53.3β56.6) | 0.29 | β65β74 | 59 | 50.8 (49.6β52.1) | 48.4 (46.7β50.0) | β0.49 | 55.0 (53.2β56.8) | 54.6 (52.2β57.0) | β0.06 | ββ₯75 | 43 | 48.4 (46.1β50.7) | 49.4 (47.0β51.8) | 0.13 | 52.5 (49.4β55.7) | 51.9 (48.1β55.6) | β0.06 | Female, age groups (y) | | | | | | | | β18β24 | 27 | 52.6 (50.1β55.1) | 52.2 (49.9β54.5) | β0.07 | 43.6 (39.1β48.2) | 50.4 (46.1β54.6) | 0.60 | β25β34 | 108 | 50.3 (48.8β51.8) | 50.8(49.6β52.0) | 0.06 | 42.1 (40.0β44.2) | 45.7 (43.6β47.8) | 0.33 | β35β44 | 91 | 51.2 (49.6β52.7) | 49.9 (48.3β51.5) | β0.17 | 44.9 (42.6β47.1) | 48.6 (46.4β50.9) | 0.35 | β45β54 | 101 | 50.5 (48.9β52.0) | 49.4 (48.0β50.8) | β0.14 | 45.1 (42.9β47.3) | 48.0 (45.8β50.2) | 0.26 | β55β64 | 72 | 49.8 (48.3β51.3) | 47.4 (45.3β49.4) | β0.38 | 47.6 (44.8β50.3) | 48.2 (45.6β50.8) | 0.05 | β65β74 | 70 | 48.4 (46.6β50.1) | 45.7 (43.6β47.9) | β0.36 | 48.0 (45.7β50.3) | 49.4 (46.2β52.5) | 0.14 | ββ₯75 | 35 | 45.7 (43.1β48.3) | 41.6 (38.2β44.9) | β0.52 | 43.8 (39.9β47.7) | 43.3 (39.5β47.0) | β0.05 | Marital status | | | | | | | | βMarried | 676 | 51.1 (50.6β51.5) | 50.0 (49.4β50.5) | β0.16 | 48.8 (48.1β49.6) | 50.6 (49.8β51.4) | 0.17 | βSingle | 412 | 51.3 (50.6β51.9) | 51.5 (50.9β52.1) | 0.04 | 48.3 (47.3β49.3) | 50.8 (49.9β51.7) | 0.24 | βWidow/divorced | 96 | 47.2 (45.6β48.8) | 45.9 (43.9β47.8) | β0.17 | 45.6 (43.0β48.1) | 47.7 (45.2β50.4) | 0.17 | Education | | | | | | | | βHigh school | 457 | 51.2 (50.6β51.8) | 51.2 (50.6β51.8) | β | 48.1 (47.1β 49.0) | 50.1 (49.2β51.0) | 0.20 | βSecondary school | 311 | 51.1 (50.3β51.9) | 50.1 (49.4β50.9) | β0.13 | 48.2 (47.1β49.4) | 51.2 (50.0β52.3) | 0.28 | βPrimary school | 227 | 49.0 (48.2β49.9) | 47.5 (46.4β48.5) | β0.23 | 49.0 (47.6β50.4) | 50.7 (49.2β52.1) | 0.16 | βDegree | 143 | 52.7 (51.8β53.6) | 52.4 (51.4β53.4) | β0.05 | 49.0 (47.4β50.7) | 50.6 (49.2β52.1) | 0.16 | βNone | 22 | 46.8 (42.6β50.9) | 44.9 (41.2β48.5) | β0.19 | 47.7 (42.9β52.6) | 43.1 (37.5β48.7) | β0.39 | Working status | | | | | | | 0.21 | βWorker | 632 | 51.7 (51.2β52.2) | 51.5 (51.0β52.0) | β0.04 | 49.2 (48.4β49.9) | 51.2 (50.5β52.0) | 0.07 | βRetired | 222 | 49.2 (48.3β50.1) | 47.6 (46.6β48.7) | β0.23 | 50.8(49.5β52.1) | 51.5 (50.0β53.0) | 0.20 | βHouse keeper | 181 | 48.9 (47.8β50.0) | 47.8 (46.6β49.0) | β0.15 | 44.9 (43.2β46.5) | 47.2 (45.5β48.9) | 0.26 | βStudent | 65 | 51.6 (50.1β53.0) | 52.3 (51.0β53.6) | 0.12 | 47.0 (44.6β49.4) | 49.7 (47.6β51.8) | 0.41 | βUnemployed | 36 | 52.2 (50.5β53.9) | 51.1 (49.5β52.7) | β0.16 | 43.9 (41.1β46.7) | 48.7 (46.3β51.0) | | Systemic diseases | | | | | | | | βNo | 933 | 51.3 (50.9β51.7) | 51.0 (50.6β51.5) | β0.04 | 48.5(47.9β 49.2) | 50.6 (50.0β51.3) | 0.20 | βYes | 249 | 49.1 (48.1β50.0) | 47.5 (46.4β48.5) | β0.21 | 48.1 (46.8β49.5) | 49.6 (48.1β51.0) | 0.13 | βUnreported | 41 | | | | | | | Clinical indications | | | | | | | | βEctasia/thinning | 721 | 51.7 (51.2β52.1) | 51.3 (50.8β51.7) | β0.07 | 48.4 (47.6β49.1) | 50.7 (50.0β51.4) | 0.23 | βAll other indications | 502 | 49.5 (48.9β50.2) | 48.7 (48.0β49.4) | β0.12 | 48.4 (47.6β49.1) | 50.1 (49.0β51.1) | 0.14 | Previous keratoplasties | | | | | | | | βNo | 1,020 | 50.9 (50.5β51.3) | 50.3 (49.8β50.7) | β0.09 | 48.3 (47.7β49.0) | 50.5 (49.8β51.1) | 0.20 | βYes | 148 | 50.1 (48.9β51.3) | 49.4 (48.1β50.6) | β0.09 | 48.4 (46.5β50.2) | 49.5 (47.6β51.5) | 0.10 | βUnreported | 55 | | | | | | | Previous ocular surgery (other than graft) | | | | | | | | βNo | 884 | 51.5 (51.0β51.9) | 50.8 (50.4β51.3) | β0.10 | 48.2 (47.5β48.9) | 50.5 (49.8β51.1) | 0.22 | βYes | 284 | 48.8 (47.9β49.6) | 48.1 (47.0β49.1) | β0.09 | 48.9 (47.5β50.2) | 50.1 (48.7β51.5) | 0.10 | βUnreported | 55 | | | | | | | Other ocular diseases | | | | | | | | βNo | 939 | 51.0 (50.6β51.5) | 50.6 (50.1β51.0) | β0.07 | 48.0 (47.4β48.7) | 50.2 (49.6β51.0) | 0.20 | βYes | 257 | 50.0 (49.1β50.9) | 49.1 (48.2β50.1) | β0.12 | 49.4 (48.1β50.7) | 51.0 (49.7β52.3) | 0.15 | βUnreported | 27 | | | | | | | Adverse reactions/complications (follow-up) | | | | | | | | βNo | 809 | 50.9 (50.4β51.4) | 50.7 (50.3β51.2) | β0.02 | 48.7 (48.0β49.4) | 50.9 (50.2β51.6) | 0.21 | βYes | 188 | 51.6 (50.6β52.5) | 49.9 (48.8β51.0) | β0.24 | 47.3 (45.8β48.7) | 48.9 (47.3β50.6) | 0.16 | βUnreported | 226 | | | | | | | BCVAΒ§ (at baseline) | | | | | | | | ββ€2/10 | 922 | 50.7 (50.3β51.2) | 50.4 (49.6β50.5) | β0.10 | 48.5 (47.9β49.2) | 50.6 (49.9β51.3) | 0.20 | β3/10-4/10 | 188 | 50.8 (49.9β51.7) | 51.1 (50.2β52.0) | 0.04 | 48.6 (47.1β50.1) | 49.8 (48.2β51.3) | 0.11 | β5/10-7/10 | 76 | 51.7 (50.1β53.4) | 50.4 (48.8β52.0) | β0.18 | 46.8 (44.0β49.6) | 50.7 (48.4β52.9) | 0.31 | ββ₯8/10 | 5 | 52.1 (43.3β60.9) | 47.7 (37.5β57.9) | β0.62 | 50.9 (34.4β67.3) | 55.9 (48.1β63.7) | 0.38 | βUnreported | 32 | | | | | | |
|
|
*Negative values of ES indicate poorer SF-12 scores compared to baseline; Β§best corrected visual acuity.
|